Bio Gene (Australia) Odds of Future Stock Price Finishing Under 0.096
| BGT Stock | 0.04 0 2.44% |
Bio |
Bio Gene Target Price Odds to finish below 0.096
The tendency of Bio Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under 0.1 after 90 days |
| 0.04 | 90 days | 0.1 | close to 99 |
Based on a normal probability distribution, the odds of Bio Gene to stay under 0.1 after 90 days from now is close to 99 (This Bio Gene Technology probability density function shows the probability of Bio Stock to fall within a particular range of prices over 90 days) . Probability of Bio Gene Technology price to stay between its current price of 0.04 and 0.1 at the end of the 90-day period is about 87.31 .
Assuming the 90 days trading horizon Bio Gene has a beta of 0.39 suggesting as returns on the market go up, Bio Gene average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Bio Gene Technology will be expected to be much smaller as well. Additionally Bio Gene Technology has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Bio Gene Price Density |
| Price |
Predictive Modules for Bio Gene
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bio Gene Technology. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Bio Gene Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Bio Gene is not an exception. The market had few large corrections towards the Bio Gene's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Bio Gene Technology, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Bio Gene within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.11 | |
β | Beta against Dow Jones | 0.39 | |
σ | Overall volatility | 0.01 | |
Ir | Information ratio | -0.04 |
Bio Gene Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Bio Gene for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Bio Gene Technology can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Bio Gene Technology generated a negative expected return over the last 90 days | |
| Bio Gene Technology has some characteristics of a very speculative penny stock | |
| Bio Gene Technology has high historical volatility and very poor performance | |
| Bio Gene Technology has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 18.32 K. Net Loss for the year was (2.41 M) with profit before overhead, payroll, taxes, and interest of 222.1 K. | |
| Bio Gene generates negative cash flow from operations | |
| About 43.0% of the company shares are held by company insiders |
Bio Gene Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Bio Stock often depends not only on the future outlook of the current and potential Bio Gene's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bio Gene's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 185.8 M | |
| Cash And Short Term Investments | 2.2 M |
Bio Gene Technical Analysis
Bio Gene's future price can be derived by breaking down and analyzing its technical indicators over time. Bio Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Bio Gene Technology. In general, you should focus on analyzing Bio Stock price patterns and their correlations with different microeconomic environments and drivers.
Bio Gene Predictive Forecast Models
Bio Gene's time-series forecasting models is one of many Bio Gene's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Bio Gene's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Bio Gene Technology
Checking the ongoing alerts about Bio Gene for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Bio Gene Technology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Bio Gene Technology generated a negative expected return over the last 90 days | |
| Bio Gene Technology has some characteristics of a very speculative penny stock | |
| Bio Gene Technology has high historical volatility and very poor performance | |
| Bio Gene Technology has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 18.32 K. Net Loss for the year was (2.41 M) with profit before overhead, payroll, taxes, and interest of 222.1 K. | |
| Bio Gene generates negative cash flow from operations | |
| About 43.0% of the company shares are held by company insiders |
Additional Tools for Bio Stock Analysis
When running Bio Gene's price analysis, check to measure Bio Gene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Gene is operating at the current time. Most of Bio Gene's value examination focuses on studying past and present price action to predict the probability of Bio Gene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Gene's price. Additionally, you may evaluate how the addition of Bio Gene to your portfolios can decrease your overall portfolio volatility.